Literature DB >> 2524553

Studies on the mechanism of protection from acute viral encephalomyelitis by delayed-type hypersensitivity inducer T cell clones.

S S Erlich1, G K Matsushima, S A Stohlman.   

Abstract

Previous studies have shown that mice can be protected from a lethal infection with the neurotropic JHM strain of mouse hepatitis virus (JHMV) by the adoptive transfer of delayed-type hypersensitivity (DTH)-inducer T cell clones specific for the virus. Protection does not involve the suppression of virus replication in the central nervous system (CNS) or via augmentation of the antiviral antibody response. In the present report we have compared the CNS lesions induced by JHMV in lethally infected and T cell clone protected mice. The presence of virus-specific T cell clones induced a transient increase in mononuclear cell infiltration into the parenchyma of the brains of protected mice, consistent with previous data suggesting that a DTH response was responsible for protection. Immunohistochemical studies suggested further that virus was not replicating in the ependyma or cellular infiltrate, but that the presence of the T cell clone prevented neuronal infection. While the mechanism of effectively altering the in vivo cellular tropism is unknown, survival is accompanied by increased specific destruction of target tissues with fulminant CNS demyelination and an increased incidence of persistent infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524553      PMCID: PMC7130132          DOI: 10.1016/0022-510x(89)90102-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  22 in total

1.  Experimental neuropathology of chronic demyelination induced by a JHM virus variant (DS).

Authors:  S S Erlich; J O Fleming; S A Stohlman; L P Weiner
Journal:  Arch Neurol       Date:  1987-08

2.  In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication.

Authors:  S A Stohlman; G K Matsushima; N Casteel; L P Weiner
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

3.  Pathogenesis of demyelination induced by a mouse hepatitis.

Authors:  L P Weiner
Journal:  Arch Neurol       Date:  1973-05

4.  Hybridoma antibodies to the murine coronavirus JHM: characterization of epitopes on the peplomer protein (E2).

Authors:  H Wege; R Dörries; H Wege
Journal:  J Gen Virol       Date:  1984-11       Impact factor: 3.891

5.  Macrophage antiviral activity: extrinsic versus intrinsic activity.

Authors:  S A Stohlman; J G Woodward; J A Frelinger
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

6.  Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody.

Authors:  M J Buchmeier; H A Lewicki; P J Talbot; R L Knobler
Journal:  Virology       Date:  1984-01-30       Impact factor: 3.616

7.  Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection.

Authors:  S A Stohlman; J A Frelinger; L P Weiner
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

8.  Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus.

Authors:  J O Fleming; S A Stohlman; R C Harmon; M M Lai; J A Frelinger; L P Weiner
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

9.  Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis.

Authors:  J O Fleming; R A Shubin; M A Sussman; N Casteel; S A Stohlman
Journal:  Virology       Date:  1989-01       Impact factor: 3.616

10.  A MURINE VIRUS (JHM) CAUSING DISSEMINATED ENCEPHALOMYELITIS WITH EXTENSIVE DESTRUCTION OF MYELIN : II. PATHOLOGY.

Authors:  O T Bailey; A M Pappenheimer; F S Cheever; J B Daniels
Journal:  J Exp Med       Date:  1949-08-31       Impact factor: 14.307

View more
  6 in total

1.  Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells.

Authors:  J S Williamson; S A Stohlman
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

2.  Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system.

Authors:  S A Stohlman; C C Bergmann; R C van der Veen; D R Hinton
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

3.  Coronavirus induced primary demyelination: indications for the involvement of a humoral immune response.

Authors:  F Zimprich; J Winter; H Wege; H Lassmann
Journal:  Neuropathol Appl Neurobiol       Date:  1991-12       Impact factor: 8.090

4.  Relapsing encephalomyelitis following transfer of partial immunity to JHM virus.

Authors:  R A Shubin; M A Sussman; J O Fleming; S A Stohlman
Journal:  Microb Pathog       Date:  1990-05       Impact factor: 3.738

5.  Mouse hepatitis virus nucleocapsid protein-specific cytotoxic T lymphocytes are Ld restricted and specific for the carboxy terminus.

Authors:  S A Stohlman; S Kyuwa; M Cohen; C Bergmann; J M Polo; J Yeh; R Anthony; J G Keck
Journal:  Virology       Date:  1992-07       Impact factor: 3.616

6.  Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM.

Authors:  J S Williamson; K C Sykes; S A Stohlman
Journal:  J Neuroimmunol       Date:  1991-06       Impact factor: 3.478

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.